SRL
PHIO icon

Scientech Research LLC’s Phio Pharmaceuticals PHIO Stock Holding History

Scientech Research LLC’s Portfolio PHIO Stock Details PHIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$36.6K Buy
+30,032
New +$34.3K 0.03% 424

Other funds holding PHIO

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Scientech Research LLC's PHIO Position: Q1 2026 in Review

Scientech Research LLC opened a new position in Phio Pharmaceuticals (PHIO) in Q1 2026: 30,032 shares worth $36.6K. The stake represents 0.03% of the portfolio and ranks #424 among its holdings.

24 funds tracked by Wall St. Rank hold PHIO as of Q1 2026.

  • Scientech Research LLC held 30,032 shares of Phio Pharmaceuticals worth $36.6K as of Q1 2026.
  • Phio Pharmaceuticals was a new Scientech Research LLC position in Q1 2026.
  • Phio Pharmaceuticals made up 0.03% of Scientech Research LLC's portfolio in Q1 2026, its #424 holding.
  • 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q1 2026.

Based on Scientech Research LLC's 13F filing for Q1 2026, filed 15 May 2026.